Omega 3-rich Camelina sativa oil in the context of a weight loss program improves glucose homeostasis, inflammation and oxidative stress in patients with NAFLD: A randomised placebo-controlled clinical trial.
Vali MusazadehParvin DehghanSevda Saleh-GhadimiMahdieh Abbasalizad FarhangiPublished in: International journal of clinical practice (2021)
These findings indicate that CSO may improve glycemia, inflammation, metabolic endotoxemia, and oxidative stress status in patients with NAFLD.
Keyphrases
- oxidative stress
- clinical trial
- double blind
- placebo controlled
- weight loss
- study protocol
- phase ii
- diabetic rats
- open label
- dna damage
- induced apoptosis
- ischemia reperfusion injury
- phase iii
- bariatric surgery
- randomized controlled trial
- roux en y gastric bypass
- phase ii study
- lps induced
- heat shock
- radiation therapy
- inflammatory response
- squamous cell carcinoma
- type diabetes
- insulin resistance
- skeletal muscle